Israeli Drugmaker Teva in Talks to Help Produce Covid-19 Vaccines
Teva Pharmaceuticals Could Face Billions in Damages From Opioid Lawsuits | Barron's
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters")
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Gets Fresh Cash, Fresh Woes | Ctech
Teva: Now What? | Barron's
Teva says its generic Adderall shortage will last another 2 to 3 months (NYSE:TEVA) | Seeking Alpha
Justice Dept reportedly may file charges in its generic-drug probe by year-end
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Ex-Teva Chairman, Blockchain Investor Accused of Pump-and-Dump Scheme - WSJ
CVS, Teva, Allergan and Endo reach $878 million deal with Florida over the opioid crisis - STAT
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
252 Teva Pharmaceuticals Photos and Premium High Res Pictures - Getty Images
Teva Offers Drugs Valued at $23 Billion to End Opioid Suits - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
With New Teva Deal, Combined NY Settlements With Opioid Makers Top $2 Billion | New York Law Journal
Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva Hit With New Lawsuit Over Proposed Korlym Drug Copy
Teva Agrees to Purchase Rimsa in $2.3 Billion Deal
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
